News
06-19-2010, 05:30 AM
For the second time within a year, an experimental drug invented by cancer researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) is being tested on patients in a clinical trial.
More... (http://www.news-medical.net/news/20100619/New-phase-IIIa-clinical-trial-of-AR-42-for-blood-cancer-at-OSUCCC-James.aspx)
More... (http://www.news-medical.net/news/20100619/New-phase-IIIa-clinical-trial-of-AR-42-for-blood-cancer-at-OSUCCC-James.aspx)